Franklin Resources’s Jasper Therapeutics JSPR Stock Holding History

Franklin Resources’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-534,713	Closed	-$2.97M	–	3198
2025 Q2	$2.97M	Hold	534,713	–	–	﹤0.01%	1566
2025 Q1	$2.3M	Sell	534,713 -44,923	-8%	-$299K	﹤0.01%	1637
2024 Q4	$12.4M	Hold	579,636	–	–	﹤0.01%	1058
2024 Q3	$9.61M	Sell	579,636 -118,900	-17%	-$2.37M	﹤0.01%	1140
2024 Q2	$15.9M	Sell	698,536 -23,538	-3%	-$565K	﹤0.01%	937
2024 Q1	$21.2M	Buy	+722,074	New	+$12.8M	0.01%	846
2023 Q4	–	Sell	-450,022	Closed	-$3.15M	–	2678
2023 Q3	$3.15M	Hold	450,022	–	–	﹤0.01%	1227
2023 Q2	$6.17M	Hold	450,022	–	–	﹤0.01%	1050
2023 Q1	$8.15M	Buy	+450,022	New	+$8.32M	﹤0.01%	974

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Franklin Resources's JSPR Position: Q3 2025 in Review

Franklin Resources sold out of Jasper Therapeutics (JSPR) in Q3 2025, closing a stake of 534,713 shares — an estimated $2.97M sold.

Franklin Resources first reported a position in JSPR in Q1 2023 and held it in 9 quarters. The position peaked at $21.2M in Q1 2024. 60 funds tracked by Wall St. Rank hold JSPR as of Q3 2025.

Franklin Resources reported no remaining Jasper Therapeutics position as of Q3 2025 after selling out during the quarter.
Franklin Resources sold 534,713 Jasper Therapeutics shares in Q3 2025, an estimated $2.97M.
Franklin Resources first reported a position in Jasper Therapeutics in Q1 2023 and held it in 9 quarters.
Franklin Resources's Jasper Therapeutics position peaked at $21.2M in Q1 2024.
60 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.